Dichos y Refranes

Descargar Outcomes Intermediate en PPS

Outcomes Intermediate PPS, página 6

Outcomes Intermediate: 5530 Libros PPS

  1. Logic Model Template

     
    Tipo: Presentación Powerpoint
    #6 Surrogates Outcomes for Cardiovascular Drug Eluting Stents; #23 Imaging ... An intermediate endpoints is identified by Temple (JAMA, 1999) as a clinical ... Surrogate Endpoints: A Regulatory View.
    https://www.acgov.org/ece/documents/meetings/stratplanframe9.18.14.ppt
  2.  
    Tipo: Presentación Powerpoint

  3. CME Faculty Slides_Update Diabetes Meds

     
    Tipo: Presentación Powerpoint
    #6 Surrogates Outcomes for Cardiovascular Drug Eluting Stents; #23 Imaging ... An intermediate endpoints is identified by Temple (JAMA, 1999) as a clinical ... Surrogate Endpoints: A Regulatory View.
    https://www.baylorcme.org/trans/ppts/type-2-diabetes-medications.ppt

  4. Understanding Evaluation

     
    Tipo: Presentación Powerpoint
    #6 Surrogates Outcomes for Cardiovascular Drug Eluting Stents; #23 Imaging ... An intermediate endpoints is identified by Temple (JAMA, 1999) as a clinical ... Surrogate Endpoints: A Regulatory View.
    https://www.clinks.org/sites/default/files/2019-10/GRANTS%20presentation%20-%20September%202019%20%28003%29.ppt

  5. General

     
    Tipo: Presentación Powerpoint
    #6 Surrogates Outcomes for Cardiovascular Drug Eluting Stents; #23 Imaging ... An intermediate endpoints is identified by Temple (JAMA, 1999) as a clinical ... Surrogate Endpoints: A Regulatory View.
    https://www.dol.gov/sites/dolgov/files/ETA/reports/pdfs/Effects%20of%20Customer%20Choice_First%20Findings.ppt

  6. Slide 1

     
    Tipo: Presentación Powerpoint
    #6 Surrogates Outcomes for Cardiovascular Drug Eluting Stents; #23 Imaging ... An intermediate endpoints is identified by Temple (JAMA, 1999) as a clinical ... Surrogate Endpoints: A Regulatory View.
    https://www.portlandchildrenslevy.org/file/173/download?token=tl9hgEGS

  7. ACSD / AARM - 2

     
    Tipo: Presentación Powerpoint
    #6 Surrogates Outcomes for Cardiovascular Drug Eluting Stents; #23 Imaging ... An intermediate endpoints is identified by Temple (JAMA, 1999) as a clinical ... Surrogate Endpoints: A Regulatory View.
    http://www.jposc.undp.org/content/dam/jposc/docs/Workshops/Maputo%202009/UNDP-JPOSC-M&EBasics_workshop_maputo2009_en.ppt

  8. Slide 1

     
    Tipo: Presentación Powerpoint
    #6 Surrogates Outcomes for Cardiovascular Drug Eluting Stents; #23 Imaging ... An intermediate endpoints is identified by Temple (JAMA, 1999) as a clinical ... Surrogate Endpoints: A Regulatory View.
    https://p2infohouse.org/ref/51/50106.ppt

  9. Surrogate Endpoints: A Regulatory View

     
    Tipo: Presentación Powerpoint
    #6 Surrogates Outcomes for Cardiovascular Drug Eluting Stents; #23 Imaging ... An intermediate endpoints is identified by Temple (JAMA, 1999) as a clinical ... Surrogate Endpoints: A Regulatory View.
    https://ww2.amstat.org/meetings/fdaworkshop/presentations/2006/Greg%20Campbell%20Surrogate%20Endpoints.ppt

Libro en otros formatos:


Arriba